Ustekinumab Rivals Face Exclusion Until 2025

J&J Believes Stelara Will Not Face Biosimilar Competition This Year Or Next

 
• By Dave Wallace
  
Man in suit and tie points to year 2025
J&J says it does not expect Stelara biosimilars until 2025 • Source: Shutterstock

More from Biosimilars

More from Products